Skinvisible, Inc. (SKVI)
0.201
0.00 (0.00%)
USD |
OTCM |
Sep 23, 16:00
Skinvisible Accounts Receivable (Quarterly) : 0.0226M for June 30, 2026
Accounts Receivable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Accounts Receivable (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0226M |
| March 31, 2026 | 0.0226M |
| December 31, 2025 | 0.0226M |
| September 30, 2025 | 0.0226M |
| June 30, 2025 | 0.0226M |
| March 31, 2025 | 0.0181M |
| December 31, 2024 | 0.0226M |
| September 30, 2024 | 0.0226M |
| June 30, 2024 | 0.0226M |
| March 31, 2024 | 0.0226M |
| December 31, 2023 | 0.0266M |
| September 30, 2023 | 0.0482M |
| June 30, 2023 | 0.0482M |
| March 31, 2023 | 0.0402M |
| December 31, 2022 | 0.0191M |
| September 30, 2022 | 0.005M |
| June 30, 2022 | 0.005M |
| March 31, 2022 | 0.005M |
| December 31, 2021 | 0.0001M |
| September 30, 2021 | 0.005M |
| June 30, 2021 | 0.0061M |
| March 31, 2021 | 0.0065M |
| December 31, 2020 | 0.0077M |
| September 30, 2020 | 0.0108M |
| June 30, 2020 | 0.0146M |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0084M |
| December 31, 2019 | 0.0102M |
| September 30, 2019 | 0.0094M |
| June 30, 2019 | 0.0099M |
| March 31, 2019 | 0.0051M |
| December 31, 2018 | 0.0085M |
| September 30, 2018 | 0.0114M |
| June 30, 2018 | 0.0124M |
| March 31, 2018 | 0.0097M |
| December 31, 2017 | 0.0099M |
| September 30, 2017 | 0.0081M |
| June 30, 2017 | 0.0095M |
| March 31, 2017 | 0.0063M |
| December 31, 2016 | 0.01M |
| September 30, 2016 | 0.0077M |
| June 30, 2016 | 0.0073M |
| March 31, 2016 | 0.0064M |
| December 31, 2015 | 0.005M |
| September 30, 2015 | 0.0068M |
| June 30, 2015 | 0.0061M |
| March 31, 2015 | 0.0057M |
| December 31, 2014 | 0.0095M |
| September 30, 2014 | 0.0206M |
| June 30, 2014 | 0.0075M |
| March 31, 2014 | 0.0055M |
Accounts Receivable Definition
Represents change in working capital due to increase or decrease in receivables for the given period.
Accounts Receivable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Receivable (Quarterly) Benchmarks
| Medifast, Inc. | -- |
| Integrated BioPharma, Inc. | 3.655M |
| BioForce Nanosciences Holdings, Inc. | -- |
| Nevis Brands, Inc. | 0.156M |
| Skinhealth Systems, Inc. | 17.64M |